...
tern-img

Terns Pharmaceuticals Inc, Common Stock

TERN

NSQ

$6.98

+$0.25

(3.71%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$571.64M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.62M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-0.33
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$4.32 L
$11.4 H
$6.98

About Terns Pharmaceuticals Inc, Common Stock

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology, metabolic dysfunction-associated steatohepatitis (MASH), and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of MASH; and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameTERNSectorS&P500
1-Week Return6.08%-3.72%-0.05%
1-Month Return22.46%-1.85%2.75%
3-Month Return-25.82%-11.4%7.4%
6-Month Return-12.31%-4.41%10.47%
1-Year Return7.55%4.13%27.57%
3-Year Return23.54%0.3%29.56%
5-Year Return-62.04%36.62%89.3%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue--1.00M--[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue195.00K394.00K512.00K1.03M881.00K[{"date":"2019-12-31","value":18.9,"profit":true},{"date":"2020-12-31","value":38.18,"profit":true},{"date":"2021-12-31","value":49.61,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":85.37,"profit":true}]
Gross Profit(195.00K)(394.00K)1.00M(1.03M)(881.00K)[{"date":"2019-12-31","value":-19.5,"profit":false},{"date":"2020-12-31","value":-39.4,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-103.2,"profit":false},{"date":"2023-12-31","value":-88.1,"profit":false}]
Gross Margin(Infinity%)(Infinity%)100.00%(Infinity%)(Infinity%)[{"date":"2019-12-31","value":null,"profit":false},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Operating Expenses70.20M37.02M50.86M62.03M102.56M[{"date":"2019-12-31","value":68.45,"profit":true},{"date":"2020-12-31","value":36.1,"profit":true},{"date":"2021-12-31","value":49.59,"profit":true},{"date":"2022-12-31","value":60.48,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(70.20M)(37.02M)(49.86M)(62.03M)(102.56M)[{"date":"2019-12-31","value":-7019700000,"profit":false},{"date":"2020-12-31","value":-3702500000,"profit":false},{"date":"2021-12-31","value":-4986000000,"profit":false},{"date":"2022-12-31","value":-6202900000,"profit":false},{"date":"2023-12-31","value":-10255800000,"profit":false}]
Total Non-Operating Income/Expense2.56M(2.68M)380.00K4.15M25.49M[{"date":"2019-12-31","value":10.05,"profit":true},{"date":"2020-12-31","value":-10.51,"profit":false},{"date":"2021-12-31","value":1.49,"profit":true},{"date":"2022-12-31","value":16.29,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(68.84M)(39.76M)(49.65M)(59.99M)(89.97M)[{"date":"2019-12-31","value":-6883900000,"profit":false},{"date":"2020-12-31","value":-3975800000,"profit":false},{"date":"2021-12-31","value":-4965000000,"profit":false},{"date":"2022-12-31","value":-5998700000,"profit":false},{"date":"2023-12-31","value":-8997100000,"profit":false}]
Income Taxes(20.00K)813.00K508.00K358.00K239.00K[{"date":"2019-12-31","value":-2.46,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":62.48,"profit":true},{"date":"2022-12-31","value":44.03,"profit":true},{"date":"2023-12-31","value":29.4,"profit":true}]
Income After Taxes(68.82M)(40.57M)(50.16M)(60.34M)(90.21M)[{"date":"2019-12-31","value":-6881900000,"profit":false},{"date":"2020-12-31","value":-4057100000,"profit":false},{"date":"2021-12-31","value":-5015800000,"profit":false},{"date":"2022-12-31","value":-6034500000,"profit":false},{"date":"2023-12-31","value":-9021000000,"profit":false}]
Income From Continuous Operations(68.82M)(40.57M)(50.16M)(60.34M)(90.21M)[{"date":"2019-12-31","value":-6881900000,"profit":false},{"date":"2020-12-31","value":-4057100000,"profit":false},{"date":"2021-12-31","value":-5015800000,"profit":false},{"date":"2022-12-31","value":-6034500000,"profit":false},{"date":"2023-12-31","value":-9021000000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(68.82M)(40.57M)(50.16M)(60.34M)(90.21M)[{"date":"2019-12-31","value":-6881900000,"profit":false},{"date":"2020-12-31","value":-4057100000,"profit":false},{"date":"2021-12-31","value":-5015800000,"profit":false},{"date":"2022-12-31","value":-6034500000,"profit":false},{"date":"2023-12-31","value":-9021000000,"profit":false}]
EPS (Diluted)-(30.94)(2.34)(1.83)(1.27)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-3094,"profit":false},{"date":"2021-12-31","value":-234,"profit":false},{"date":"2022-12-31","value":-183,"profit":false},{"date":"2023-12-31","value":-127,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

TERN
Cash Ratio 32.67
Current Ratio 32.99

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

TERN
ROA (LTM) -19.23%
ROE (LTM) -28.28%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

TERN
Debt Ratio Lower is generally better. Negative is bad. 0.04
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.96

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

TERN
Trailing PE NM
Forward PE NM
P/S (TTM) 302.64
P/B 1.57
Price/FCF NM
EV/R 337.47
EV/Ebitda NM

FAQs

What is Terns Pharmaceuticals Inc share price today?

Terns Pharmaceuticals Inc (TERN) share price today is $6.98

Can Indians buy Terns Pharmaceuticals Inc shares?

Yes, Indians can buy shares of Terns Pharmaceuticals Inc (TERN) on Vested. To buy Terns Pharmaceuticals Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TERN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Terns Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of Terns Pharmaceuticals Inc (TERN) via the Vested app. You can start investing in Terns Pharmaceuticals Inc (TERN) with a minimum investment of $1.

How to invest in Terns Pharmaceuticals Inc shares from India?

You can invest in shares of Terns Pharmaceuticals Inc (TERN) via Vested in three simple steps:

  • Click on Sign Up or Invest in TERN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Terns Pharmaceuticals Inc shares
What is Terns Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of Terns Pharmaceuticals Inc (TERN) is $11.4. The 52-week low price of Terns Pharmaceuticals Inc (TERN) is $4.32.

What is Terns Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Terns Pharmaceuticals Inc (TERN) is

What is Terns Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Terns Pharmaceuticals Inc (TERN) is 1.57

What is Terns Pharmaceuticals Inc dividend yield?

The dividend yield of Terns Pharmaceuticals Inc (TERN) is 0.00%

What is the Market Cap of Terns Pharmaceuticals Inc?

The market capitalization of Terns Pharmaceuticals Inc (TERN) is $571.64M

What is Terns Pharmaceuticals Inc’s stock symbol?

The stock symbol (or ticker) of Terns Pharmaceuticals Inc is TERN

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top